Dr. Lakshmi Kannan, MD
What this data tells you about Dr. Kannan
Dr. Lakshmi Kannan is a hematology & oncology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kannan performed 35,857 Medicare services across 2,009 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kannan received a total of $91,185 from 62 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kannan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 13,400 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 8,580 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 5,850 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 1,500 | $0 | $3 |
| Dexamethasone injection (steroid) | 970 | $0 | $1 |
| Complete blood count (CBC) with differential | 959 | $8 | $36 |
| Blood draw (venipuncture) | 842 | $8 | $20 |
| Anti-nausea injection (Aloxi/palonosetron) | 650 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 410 | $0 | $24 |
| Office visit, established patient (30-39 min) | 407 | $96 | $368 |
| Office visit, established patient (20-29 min) | 351 | $62 | $250 |
| Comprehensive metabolic blood panel | 234 | $10 | $64 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 189 | $23 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 145 | $103 | $707 |
| Reticulated (young) platelet measurement | 112 | $35 | $143 |
| Drug injection, under skin or into muscle | 101 | $10 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 95 | $48 | $313 |
| Microscopic examination for white blood cells with manual cell count | 88 | $4 | $22 |
| Complete blood count (CBC), automated | 88 | $6 | $34 |
| Iron level test | 77 | $6 | $27 |
| Iron binding capacity test | 77 | $8 | $35 |
| Administration of chemotherapy into vein, each additional hour | 77 | $22 | $161 |
| Ferritin level test (iron stores) | 76 | $13 | $60 |
| Hospital follow-up visit, moderate complexity | 72 | $61 | $247 |
| Injection, zoledronic acid, 1 mg | 71 | $6 | $431 |
| Administration of additional new drug or substance into vein, 1 hour or less | 62 | $51 | $344 |
| Injection of additional new drug or substance into vein | 50 | $12 | $108 |
| New patient office visit (45-59 min) | 48 | $122 | $565 |
| Hospital follow-up visit, high complexity | 42 | $91 | $357 |
| Measurement of immunoglobulin light chains | 36 | $17 | $60 |
| Injection, diphenhydramine hcl, up to 50 mg | 35 | $1 | $7 |
| Red blood count automated, with additional calculations | 31 | $5 | $26 |
| Office visit, established patient, complex (40-54 min) | 22 | $135 | $496 |
| Irrigation of implanted venous access drug delivery device | 20 | $18 | $114 |
| Application of on-body injector for under skin injection | 18 | $15 | $96 |
| Ct scan of chest with contrast | 17 | $50 | $821 |
| CT scan of abdomen and pelvis with contrast | 16 | $187 | $1,067 |
| New patient office visit, complex (60-74 min) | 15 | $174 | $709 |
| Initial hospital admission, moderate complexity | 13 | $100 | $470 |
| Blood creatinine level | 11 | $5 | $31 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (58%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for hematology & oncology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kannan is a mixed practice specialist, with above-average Medicare volume (top 26% in TX), with consulting-driven industry engagement in the top 8% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kannan experienced with iron sucrose injection (venofer)?
Does Dr. Kannan receive payments from pharmaceutical companies?
How do Dr. Kannan's costs compare to other hematology & oncology specialists in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology